BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22828828)

  • 21. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.
    Ettl T; Baader K; Stiegler C; Müller M; Agaimy A; Zenk J; Kühnel T; Gosau M; Zeitler K; Schwarz S; Brockhoff G
    Br J Cancer; 2012 Feb; 106(4):719-26. PubMed ID: 22240798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
    Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
    Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M
    J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
    Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K; Russell JS; McDermott JD; Elvin JA; Khaira D; Johnson A; Jennings TA; Ali SM; Murray M; Marshall C; Oldham DS; Washburn D; Wong SJ; Chmielecki J; Yelensky R; Lipson D; Miller VA; Stephens PJ; Serracino HS; Ross JS; Bowles DW
    Clin Cancer Res; 2016 Dec; 22(24):6061-6068. PubMed ID: 27334835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of cervical lymph node metastasis in salivary gland cancer.
    Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
    Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.
    Clauditz TS; Gontarewicz A; Lebok P; Tsourlakis MC; Grob TJ; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
    Oral Oncol; 2012 Oct; 48(10):991-996. PubMed ID: 22694907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
    Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.
    Schneider T; Strehl A; Linz C; Brands R; Hartmann S; Beckford F; Rosenwald A; Kübler AC; Müller-Richter UD
    Clin Oral Investig; 2016 Apr; 20(3):541-51. PubMed ID: 26245271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
    Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
    Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A; Stárek ; Kucerová V; Szépe P; Plank L
    Pathol Res Pract; 2001; 197(9):621-6. PubMed ID: 11569926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
    Ettl T; Schwarz-Furlan S; Haubner F; Müller S; Zenk J; Gosau M; Reichert TE; Zeitler K
    Oral Oncol; 2012 Sep; 48(9):822-30. PubMed ID: 22445095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
    Ahn MY; Ahn JW; Kim HS; Lee J; Yoon JH
    Oncol Rep; 2015 Apr; 33(4):1899-907. PubMed ID: 25647264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
    Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.
    Diegel CR; Cho KR; El-Naggar AK; Williams BO; Lindvall C
    Cancer Res; 2010 Nov; 70(22):9143-52. PubMed ID: 21062985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of methylation patterns of cancer genes in salivary gland tumors.
    Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
    Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma.
    Kondo Y; Kikuchi T; Esteban JC; Kumaki N; Ogura G; Inomoto C; Hirabayashi K; Kajiwara H; Sakai A; Sugimoto R; Otsuru M; Okami K; Tsukinoki K; Nakamura N
    Pathol Int; 2014 Sep; 64(9):453-9. PubMed ID: 25209856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.